Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

64.73
+1.472.32%
Volume:64.16K
Turnover:4.11M
Market Cap:5.74B
PE:-23.77
High:65.04
Open:62.97
Low:62.88
Close:63.26
52wk High:80.97
52wk Low:35.80
Shares:88.64M
Float Shares:77.71M
Volume Ratio:0.40
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7235
EPS(LYR):-2.0826
ROE:-26.41%
ROA:-17.67%
PB:5.58
PE(LYR):-31.08

Loading ...

Health Rounds: Experimental Cell Therapy Slows Heart Failure Progression in Duchenne Muscular Dystrophy

Reuters
·
Jul 31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)

TIPRANKS
·
Jul 28

CG Oncology announces publication of BOND-003 results in The Lancet Oncology

TIPRANKS
·
Jul 28

CG Oncology Says Phase 3 Bond-003 Data for Cretostimogene in BCG-unresponsive Bladder Cancer Publish in Lancet Oncology

Reuters
·
Jul 28

CG Oncology Director Leonard Post Disposes of 1,000 Shares for $71,170

Reuters
·
Jul 18

Ani Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

Reuters
·
Jul 17

ANI Pharmaceuticals intends to appeal rulings in CG Oncology matter

TIPRANKS
·
Jul 17

ANI Pharma Plans Delaware Supreme Court Appeal in CG Oncology Dispute

Reuters
·
Jul 17

CG Oncology Director James Mulay Disposes of Common Shares Worth $1.82 Million

Reuters
·
Jul 15

CG Oncology (CGON) In Focus Following Early Trial Results And BLA Timing Questions On Value

Simply Wall St.
·
Jul 14

Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and CG Oncology, Inc. (CGON)

TIPRANKS
·
Jul 10

CG Oncology Posts Investor Deck Highlighting Cretostimogene Data in Non-muscle Invasive Bladder Cancer Trials

Reuters
·
Jul 01

Top Insider Makes Massive Bet on CG Oncology’s Future

TIPRANKS
·
Jun 30

CG Oncology Director Brian Guan-chyun Liu Reports Purchase of $24.81 Million in Common Shares

Reuters
·
Jun 30

CG Oncology Director Leonard Post Disposes of 5,000 Common Shares Worth $350,000

Reuters
·
Jun 26

CG Oncology 1.15M share Block Trade; price range $66.87-$67.87

TIPRANKS
·
Jun 25

CG Oncology director Leonard Post disposes of 5,000 shares for $325,000

Reuters
·
Jun 24

Analysts Are Bullish on These Healthcare Stocks: PepGen Inc. (PEPG), CG Oncology, Inc. (CGON)

TIPRANKS
·
Jun 21

CG Oncology director James Mulay disposes of 1,964 common shares worth $118,795.68

Reuters
·
Jun 17

CG Oncology Shareholders Back Directors and Governance Proposals

TIPRANKS
·
Jun 09